Advances in the treatment of rheumatic disorders.
D000477:Alkylating Agents / Q000627:therapeutic use; D000493:Allopurinol / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D001178:Arthroplasty; D001241:Aspirin / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D010615:Phenacetin / Q000627:therapeutic use; D011111:Polymyalgia Rheumatica / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012213:Rheumatic Fever / Q000188:drug therapy; D013585:Synovitis / Q000601:surgery
D000477:Alkylating Agents; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D000963:Antimetabolites; D007166:Immunosuppressive Agents; D000493:Allopurinol; D006046:Gold; D011239:Prednisolone; D010615:Phenacetin; D001241:Aspirin; D011241:Prednisone; D007213:Indomethacin